Tongrentang Sinopharm (03613): Sadashi Maru [Dorentang] obtained a certificate of registration for proprietary Chinese medicines

Zhitongcaijing · 1d ago

According to the Zhitong Finance App, Tong Ren Tang Sinopharm (03613) issued an announcement. The company recently received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Hong Kong Traditional Chinese Medicine Administration to allow the sale of “Dingzhi Pills [Tong Ren Tang]” in the Hong Kong Special Administrative Region of the People's Republic of China.

The function of “Sadashi Maru [Dojindo]” is to improve qi, nourish the mind, and calm the mind. It is used for uncertain mood, lack of five organs, symptoms of being sad, sad and unhappy, uncertain and easy to forget, in the twilight drama, or when it becomes severe dizziness during a seizure. As of the date of this announcement, the Company has invested a total of approximately HK$800,000 in R&D of “Sadashi Maru [Dojindo]” (the amount has not been audited), and the product has not yet been put on the market.